Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0038358 (
gastric ulcer
)
5,179
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In eastern Australia, there is an epidemic of
gastric ulcer
which began 30 years in young women who are now middle-aged, (b) This epidemic is associated with the regular use of aspirin most often in the form of A.P.C. powders taken for non-medical reasons, (c) Data from three separate studies in America confirms a statistically significant association of regular aspirin use and chronic
gastric ulcer
, and (d) An explanation is provided by the effect of aspirin in inhibiting
prostaglandin synthetase
.
...
PMID:Aspirin and ulcers. 41 31
Nonsteroidal anti-inflammatory drugs often cause development of significant GI lesions. Selective inhibitors of
prostaglandin G/H synthase
/cyclooxygenase-2 (PGHS-2) enzyme and some dual inhibitors of PGHS/5-lipoxygenase (5-LO) enzymes have been reported to be potent anti-inflammatory compounds that carry a much lower risk of having GI irritating effects. We have evaluated the anti-inflammatory effect and the GI safety profile of three new anti-inflammatory compounds: the selective PGHS-2 inhibitors NS-398 and PD 138387 and the PGHS/5-LO dual inhibitor PD 137968. All the compounds tested showed an anti-inflammatory activity in the carragenan footpad edema test in rats. None of these compounds caused either gastric damage 4 h after p.o. administration of 100 mg/kg in rats or inhibition of PGE2 synthesis in the stomach. However, when administered p.o. at an effective anti-inflammatory dose to rats with pre-existing acetic acid-induced
gastric ulcer
, NS-398 caused a statistically significant delay of ulcer healing. No impairment of the ulcer healing was observed with the other compounds evaluated. Derivatives of 2,6-di-tert-butylphenol, whose members may act as PGHS-1/PGHS-2 inhibitors, selective PGHS-2 inhibitors or PGHS/5-LO dual inhibitors, are novel anti-inflammatory compounds that are devoid of GI irritating effects and do not affect the rate of pre-existing
gastric ulcer
healing.
...
PMID:Effects of novel anti-inflammatory compounds on healing of acetic acid-induced gastric ulcer in rats. 976 50